Viveve Medical Stock Fundamentals
| VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
Viveve Medical fundamentals help investors to digest information that contributes to Viveve Medical's financial success or failures. It also enables traders to predict the movement of Viveve Pink Sheet. The fundamental analysis module provides a way to measure Viveve Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Viveve Medical pink sheet.
Viveve |
Viveve Medical Company Return On Equity Analysis
Viveve Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Viveve Medical Return On Equity | -2.11 |
Most of Viveve Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Viveve Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Viveve Medical has a Return On Equity of -2.1099. This is 91.2% lower than that of the Health Care Equipment & Supplies sector and 75.83% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Viveve Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Viveve Medical's current stock value. Our valuation model uses many indicators to compare Viveve Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Viveve Medical competition to find correlations between indicators driving Viveve Medical's intrinsic value. More Info.Viveve Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Viveve Medical's earnings, one of the primary drivers of an investment's value.Viveve Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viveve Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Viveve Medical could also be used in its relative valuation, which is a method of valuing Viveve Medical by comparing valuation metrics of similar companies.Viveve Medical is currently under evaluation in return on equity category among its peers.
Viveve Fundamentals
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (3.10) % | ||||
| Current Valuation | 4.26 M | ||||
| Shares Outstanding | 10.72 M | ||||
| Shares Owned By Institutions | 5.21 % | ||||
| Number Of Shares Shorted | 374.24 K | ||||
| Price To Earning | (2.59) X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 6.43 M | ||||
| Gross Profit | 620 K | ||||
| EBITDA | (19.89 M) | ||||
| Net Income | (22.03 M) | ||||
| Cash And Equivalents | 9.43 M | ||||
| Cash Per Share | 0.88 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 1.12 % | ||||
| Current Ratio | 1.32 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (12.88 M) | ||||
| Short Ratio | 4.15 X | ||||
| Earnings Per Share | (2.55) X | ||||
| Price To Earnings To Growth | (0.13) X | ||||
| Target Price | 3.1 | ||||
| Number Of Employees | 47 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 1.08 M | ||||
| Total Asset | 25.91 M | ||||
| Retained Earnings | (68.62 M) | ||||
| Working Capital | 13.21 M | ||||
| Current Asset | 18.53 M | ||||
| Current Liabilities | 5.32 M | ||||
| Z Score | -2.8 | ||||
| Net Asset | 25.91 M |
About Viveve Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viveve Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viveve Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viveve Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Viveve Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |